Trial Profile
Nordic Longterm OCD treatment Study: A Nordic Multicenter treatment study evaluating a stepped care model based on the "Expert Clinical Guidelines". The study is performed with no sponsor from pharmaceutical firms
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Sep 2017
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Sertraline (Primary)
- Indications Obsessive-compulsive disorders
- Focus Therapeutic Use
- Acronyms NordLOTS; NordLOTS-step 3
- 09 Jul 2017 According to European Clinical Trials Database study has been Discontinued in Denmark.
- 08 Jan 2014 Actual end date is 31 Dec 2013 updated as reported by ISRCTN: Current Controlled Trials.
- 08 Jan 2014 Status changed from recruiting to completed as reported in ISRCTN: Current Controlled Trials.